Search results

Strategic partnership with the University of Sydney expanded to continue a long history of research collaboration.

The ANSTO Innovation Series is a live and virtual meet-up that focuses on the key capacities of ANSTO’s people, partners and facilities and how they are meeting global challenges in sustainable industries, medicine, advanced manufacturing and in accelerating small business.

Southern Cross researcher Dr Alana Gall, who recently became an ANSTO research Fellow, has been awarded more than $640,000 to lead a research program focused on First Peoples' Cultural Medicines (also called bush medicine) in Australian healthcare.

The protein mapping workhorses of the Australian Synchrotron, Macromolecular and Microfocus crystallography beamlines, MX1 and 2, continue to support important biomedical research in the development of vaccines and new therapeutics.

A world-class national research facility that uses accelerator technology to produce a powerful source of light-X rays and infrared radiation a million times brighter than the sun.

ANSTO has contributed to research on a novel therapeutic option for combatting antimicrobial-resistant Gram-negative bacteria, known as superbugs.

A “super” receptor that helps kill HIV infected cells identified.

Dr Ceri Brenner appointed new leader of the Centre for Accelerator Science